Medico Intercontinental has announced a board meeting at which it approved the financial results for the quarter and half-year ended March 31, 2025. The company reported standalone revenue from operations at ₹15.24 Cr, with a profit after tax of ₹0.53 Cr for the quarter and ₹2.57 Cr for the year. Consolidated revenue totaled ₹21.35 Cr for the quarter and ₹56.01 Cr for the year, delivering a consolidated profit after tax of ₹1.17 Cr for the quarter and ₹5.06 Cr for the year. The board appointed Agarwal & Mehta LLP as Secretarial Auditor for five years and re-appointed MJV & Co as Internal Auditor for FY 2025-26. The statutory auditor issued an unmodified opinion on the audited financials, affirming the company’s sound financial controls and going concern status.